Courier Capital LLC Acquires 30,000 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC)

Courier Capital LLC increased its holdings in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) by 76.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 69,000 shares of the medical technology company’s stock after buying an additional 30,000 shares during the period. Courier Capital LLC’s holdings in Alphatec were worth $633,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of ATEC. Atria Investments Inc raised its position in shares of Alphatec by 8.0% during the 3rd quarter. Atria Investments Inc now owns 19,609 shares of the medical technology company’s stock valued at $109,000 after acquiring an additional 1,460 shares during the last quarter. Entropy Technologies LP grew its stake in shares of Alphatec by 14.9% during the third quarter. Entropy Technologies LP now owns 21,623 shares of the medical technology company’s stock worth $120,000 after purchasing an additional 2,800 shares during the period. Wrapmanager Inc. increased its holdings in Alphatec by 9.5% in the third quarter. Wrapmanager Inc. now owns 38,399 shares of the medical technology company’s stock valued at $213,000 after purchasing an additional 3,325 shares during the last quarter. Rhumbline Advisers increased its holdings in Alphatec by 2.6% in the second quarter. Rhumbline Advisers now owns 143,474 shares of the medical technology company’s stock valued at $1,499,000 after purchasing an additional 3,676 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its stake in Alphatec by 8.9% in the second quarter. The Manufacturers Life Insurance Company now owns 58,257 shares of the medical technology company’s stock valued at $609,000 after buying an additional 4,755 shares during the period. 66.35% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. HC Wainwright restated a “buy” rating and set a $20.00 target price on shares of Alphatec in a research report on Thursday, October 31st. Barclays boosted their price objective on shares of Alphatec from $19.00 to $20.00 and gave the company an “overweight” rating in a report on Tuesday, November 19th. Finally, Needham & Company LLC increased their target price on shares of Alphatec from $13.00 to $16.00 and gave the stock a “buy” rating in a report on Monday. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, Alphatec currently has an average rating of “Moderate Buy” and a consensus target price of $17.44.

Alphatec Stock Performance

Shares of ATEC opened at $10.88 on Tuesday. The firm’s 50 day moving average price is $9.44 and its two-hundred day moving average price is $7.99. The company has a debt-to-equity ratio of 30.21, a quick ratio of 1.15 and a current ratio of 2.32. Alphatec Holdings, Inc. has a twelve month low of $4.88 and a twelve month high of $17.34. The firm has a market cap of $1.54 billion, a P/E ratio of -8.50 and a beta of 1.41.

About Alphatec

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.